Global Liposomes Drug Delivery Market 2016 Industry Trend and Forecast 2021
- QYR1028881
- 179 Pages
- March 2017
- Pharmaceuticals
Firstly, the report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The Liposomes Drug Delivery market analysis is provided for the international market including development history, competitive landscape analysis, and major regions’ development status.
Secondly, development policies and plans are discussed as well as manufacturing processes and cost structures. This report also states import/export, supply and consumption figures as well as cost, price, revenue and gross margin by regions (North America, Europe, China and Asia (Ex. China)), and other regions can be added.
Then, the report focuses on global major leading industry players with information such as company profiles, product picture and specification, capacity, production, price, cost, revenue and contact information. Upstream raw materials, equipment and downstream consumers analysis is also carried out. What’s more, the Liposomes Drug Delivery industry development trends and marketing channels are analyzed.
Finally, the feasibility of new investment projects is assessed, and overall research conclusions are offered.
In a word, the report provides major statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market.
1 Industry Overview of Liposomes Drug Delivery 1
1.1 Definition and Specifications of Liposomes Drug Delivery 1
1.1.1 Definition of Liposomes Drug Delivery 1
1.1.2 Structure of Liposomes 3
1.2 Classification of Liposomes Drug Delivery 4
1.3 Applications of Liposomes Drug Delivery 5
1.3.1 Fungal Infection Therapy 6
1.3.2 Cancer Therapy 6
1.4 Formulations of Liposomes Drug Delivery 7
1.5 Industry Chain Structure of Liposomes Drug Delivery 9
1.6 Industry Overview and Major Regions Status of Liposomes Drug Delivery 9
1.7 Industry News Analysis of Liposomes Drug Delivery 11
2 Manufacturing Cost Structure Analysis of Liposomes Drug Delivery 14
2.1 Raw Material Suppliers Analysis of Liposomes Drug Delivery 14
2.2 Labor Cost Analysis of Liposomes Drug Delivery 15
2.3 Other Costs Analysis of Liposomes Drug Delivery 16
2.4 Manufacturing Cost Structure Analysis of Liposomes Drug Delivery 16
2.5 Mechanism Analysis of Liposomes Drug Delivery 17
2.6 Manufacture of Lipid Components 17
3 Technical Data and Manufacturing Plants Analysis 19
3.1 Capacity and Commercial Production Date of Global Key Manufacturers in 2015 19
3.2 Manufacturing Plants Distribution of Global Key Liposomes Drug Delivery Manufacturers in 2015 19
3.3 R&D Status and Technology Source of Global Liposomes Drug Delivery Key Manufacturers in 2014 20
3.4 Raw Materials Sources Analysis of Global Liposomes Drug Delivery Key Manufacturers in 2015 21
4 Capacity, Production and Revenue Analysis of Liposomes Drug Delivery by Regions, Types and Manufacturers 22
4.1 Global Capacity, Production and Revenue of Liposomes Drug Delivery by Regions 2011-2016 22
4.2 Global and Major Regions Capacity, Production, Revenue and Growth Rate of Liposomes Drug Delivery 2011-2016 27
4.3 Global Capacity, Production and Revenue of Liposomes Drug Delivery by Types 2011-2016 35
4.4 Global Capacity, Production and Revenue of Liposomes Drug Delivery by Manufacturers 2011-2016 38
5 Price, Cost, Gross and Gross Margin Analysis of Liposomes Drug Delivery by Regions, Types and Manufacturers 47
5.1 Price, Cost, Gross and Gross Margin Analysis of Liposomes Drug Delivery by Regions 2011-2016 47
5.2 Price, Cost, Gross and Gross Margin Analysis of Liposomes Drug Delivery by Types 2011-2016 48
5.3 Price, Cost, Gross and Gross Margin Analysis of Liposomes Drug Delivery by Manufacturers 2011-2016 50
6 Consumption Volume, Consumption Value and Sale Price Analysis of Liposomes Drug Delivery by Regions, Types and Applications 53
6.1 Global Consumption Volume and Consumption Value of Liposomes Drug Delivery by Regions 2011-2016 53
6.2 Global and Major Regions Consumption Volume, Consumption Value and Growth Rate of Liposomes Drug Delivery 2011-2016 57
6.3 Global Consumption Volume and Consumption Value of Liposomes Drug Delivery by Types 2011-2016 62
6.4 Global Consumption Volume and Consumption Value of Liposomes Drug Delivery by Applications 2011-2016 64
6.5 Sale Price of Liposomes Drug Delivery by Regions 2011-2016 67
6.6 Sale Price of Liposomes Drug Delivery by Types 2011-2016 68
6.7 Sale Price of Liposomes Drug Delivery by Applications 2011-2016 69
7 Supply, Import, Export and Consumption Analysis of Liposomes Drug Delivery 71
7.1 Supply, Consumption and Gap of Liposomes Drug Delivery 2011-2016 71
7.2 Global Capacity, Production, Price, Cost, Revenue, Supply, Import, Export and Consumption of Liposomes Drug Delivery 2011-2016 72
7.3 North America Capacity, Production, Price, Cost, Revenue, Supply, Import, Export and Consumption of Liposomes Drug Delivery 2011-2016 72
7.4 Europe Capacity, Production, Price, Cost, Revenue, Supply, Import, Export and Consumption of Liposomes Drug Delivery 2011-2016 73
7.5 China Capacity, Production, Price, Cost, Revenue, Supply, Import, Export and Consumption of Liposomes Drug Delivery 2011-2016 74
7.6 Asia (Ex. China) Capacity, Production, Price, Cost, Revenue, Supply, Import, Export and Consumption of Liposomes Drug Delivery 2011-2016 75
8 Analysis of Liposomes Drug Delivery Industry Key Manufacturers 76
8.1 Johnson & Johnson 76
8.1.1 Company Profile 76
8.1.2 Product Information 77
8.1.3 Capacity, Production, Price, Cost, Gross, and Revenue 78
8.2 Gilead Sciences 80
8.2.1 Company Profile 80
8.2.2 Product Information 81
8.2.3 Capacity, Production, Price, Cost, Gross, and Revenue 81
8.3 Luye Pharma 83
8.3.1 Company Profile 83
8.3.2 Product Information 84
8.3.3 Capacity, Production, Price, Cost, Gross, and Revenue 84
8.4 Sun Pharmaceutical 86
8.4.1 Company Profile 86
8.4.2 Product Information 87
8.4.3 Capacity, Production, Price, Cost, Gross, and Revenue 88
8.5 Pacira 89
8.5.1 Company Profile 89
8.5.2 Product Information 90
8.5.3 Capacity, Production, Price, Cost, Gross, and Revenue 91
8.6 Fudan-Zhangjiang 92
8.6.1 Company Profile 92
8.6.2 Product Information 93
8.6.3 Capacity, Production, Price, Cost, Gross, and Revenue 94
8.7 Sigma-Tau Group 96
8.7.1 Company Profile 96
8.7.2 Product Information 97
8.7.3 Capacity, Production, Price, Cost, Gross, and Revenue 98
8.8 Teva Pharmaceutical 99
8.8.1 Company Profile 99
8.8.2 Product Information 100
8.8.3 Capacity, Production, Price, Cost, Gross, and Revenue 101
8.9 CSPC 102
8.9.1 Company Profile 102
8.9.2 Product Information 103
8.9.3 Capacity, Production, Price, Cost, Gross, and Revenue 104
.10 Novartis 105
8.10.1 Company Profile 105
8.10.2 Product Information 106
8.10.3 Capacity, Production, Price, Cost, Gross, and Revenue 107
8.11 Crucell 108
8.11.1 Company Profile 108
8.11.2 Product Information 109
8.11.3 Capacity, Production, Price, Cost, Gross, and Revenue 110
8.12 Celsion Corporation 111
8.12.1 Company Profile 111
8.12.2 Product Information 112
8.12.3 Capacity, Production, Price, Cost, Gross, and Revenue 113
8.13 Kingond Pharm 115
8.13.1 Company Profile 115
8.13.2 Product Information 116
8.13.3 Capacity, Production, Price, Cost, Gross, and Revenue 116
8.14 Shanghai New Asia 118
8.14.1 Company Profile 118
8.14.2 Product Information 119
8.14.3 Capacity, Production, Price, Cost, Gross, and Revenue 119
8.15 Spectrum Pharmaceuticals 121
8.15.1 Company Profile 121
8.15.2 Product Information 122
8.15.3 Capacity, Production, Price, Cost, Gross, and Revenue 122
9 Marketing Trader or Distributor Analysis of Liposomes Drug Delivery 124
9.1 Marketing Channels Status of Liposomes Drug Delivery 124
9.2 Traders or Distributors with Contact Information of Liposomes Drug Delivery by Regions 125
9.3 Ex-work Price, Channel Price and End Buyer Price Analysis of Liposomes Drug Delivery 125
9.4 Regional Import, Export and Trade Analysis of Liposomes Drug Delivery 126
10 Industry Chain Analysis of Liposomes Drug Delivery 127
10.1 Upstream Major Raw Materials Suppliers Analysis of Liposomes Drug Delivery 127
10.2 Downstream Major Consumers Analysis of Liposomes Drug Delivery 127
10.3 Supply Chain Relationship Analysis of Liposomes Drug Delivery 129
10.4 Current Trends in Liposomes 130
11 Development Trend of Analysis of Liposomes Drug Delivery 131
11.1 Capacity, Production and Revenue Forecast of Liposomes Drug Delivery by Regions and Types 131
11.1.1 Global Capacity, Production and Revenue of Liposomes Drug Delivery by Regions 2016-2021 131
11.1.2 Global and Major Regions Capacity, Production, Revenue and Growth Rate of Liposomes Drug Delivery 2016-2021 136
11.2 Consumption Volume and Consumption Value Forecast of Liposomes Drug Delivery by Regions, Types and Applications 144
11.2.1 Global Consumption Volume and Consumption Value of Liposomes Drug Delivery by Regions 2016-2021 144
11.2.2 Global and Major Regions Consumption Volume, Consumption Value and Growth Rate of Liposomes Drug Delivery 2016-2021 147
11.3 Supply, Import, Export and Consumption Forecast of Liposomes Drug Delivery 152
11.3.1 Supply, Consumption and Gap of Liposomes Drug Delivery 2016-2021 152
11.3.2 Global Capacity, Production, Price, Cost, Revenue, Supply, Import, Export and Consumption of Liposomes Drug Delivery 2016-2021 154
11.3.3 North America Capacity, Production, Price, Cost, Revenue, Supply, Import, Export and Consumption of Liposomes Drug Delivery 2016-2021 154
11.3.4 Europe Capacity, Production, Price, Cost, Revenue, Supply, Import, Export and Consumption of Liposomes Drug Delivery 2016-2021 155
11.3.5 China Capacity, Production, Price, Cost, Revenue, Supply, Import, Export and Consumption of Liposomes Drug Delivery 2016-2021 155
11.3.6 Asia (Ex China) Capacity, Production, Price, Cost, Revenue, Supply, Import, Export and Consumption of Liposomes Drug Delivery 2016-2021 156
12 New Project Investment Feasibility Analysis of Liposomes Drug Delivery 157
12.1 New Project SWOT Analysis of Liposomes Drug Delivery 157
12.2 New Project Investment Feasibility Analysis of Liposomes Drug Delivery 158
13 Conclusion of the Global Liposomes Drug Delivery Industry 2016 Market Research Report 159
Figure Picture of Liposomes Drug Delivery 1
Figure Advantage Vs Disadvantage of Liposomes Drug Delivery 3
Figure Basic Reasons for using liposomes as Drug carriers 4
Table Classification of Liposomes Drug Delivery 4
Figure Global Production Market Share of Liposomes Drug Delivery by Types in 2015 5
Table Applications of Liposomes Drug Delivery 5
Figure Global Consumption Volume Market Share of Liposomes Drug Delivery by Applications in 2015 6
Figure Industry Chain Structure of Liposomes Drug Delivery 9
Table Global Industry Overview of Liposomes Drug Delivery 9
Table Industry News List of Liposomes Drug Delivery 11
Table Raw Material Suppliers and Price Analysis 14
Figure 2015 APAC Overview of Average Monthly Labor Cost (USD) 15
Figure 2015 Americas Overview of Average Monthly Labor Cost (USD) 15
Figure 2015 EMEA Overview of Average Monthly Labor Cost (USD) 16
Table Manufacturing Cost Structure Analysis of Liposomes Drug Delivery in 2015 16
Figure Mechanism Analysis of Liposomes Drug Delivery 17
Table Capacity (K Unit) and Commercial Production Date of Global Liposomes Drug Delivery Key Manufacturers in 2014 19
Table Headquarters Distribution of Global Key Liposomes Drug Delivery Manufacturers 19
Table R&D Status and Technology Source of Global Liposomes Drug Delivery Key Manufacturers in 2014 20
Table Raw Materials Sources Analysis of Global and China Liposomes Drug Delivery Key Manufacturers in 2015 21
Table Global Capacity (K Unit) of Liposomes Drug Delivery by Regions 2011-2016 22
Figure Global Capacity Market Share of Liposomes Drug Delivery by Regions in 2011 23
Figure Global Capacity Market Share of Liposomes Drug Delivery by Regions in 2015 23
Table Global Production (K Unit) of Liposomes Drug Delivery by Regions 2011-2016 24
Figure Global Production Market Share of Liposomes Drug Delivery by Regions in 2011 24
Figure Global Production Market Share of Liposomes Drug Delivery by Regions in 2015 25
Table Global Revenue (M USD) of Liposomes Drug Delivery by Regions 2011-2016 25
Figure Global Revenue Market Share of Liposomes Drug Delivery by Regions in 2011 26
Figure Global Revenue Market Share of Liposomes Drug Delivery by Regions in 2015 26
Figure Global Capacity (K Unit), Production (K Unit) and Growth Rate of Liposomes Drug Delivery 2011-2016 27
Figure Global Capacity Utilization Rate of Liposomes Drug Delivery 2011-2016 28
Figure Global Revenue (M USD) and Growth Rate of Liposomes Drug Delivery 2011-2016 28
Figure North America Capacity (K Unit), Production (K Unit) and Growth Rate of Liposomes Drug Delivery 2011-2016 29
Figure North America Capacity Utilization Rate of Liposomes Drug Delivery 2011-2016 29
Figure North America Revenue (M USD) and Growth Rate of Liposomes Drug Delivery 2011-2016 30
Figure Europe Capacity (K Unit), Production (K Unit) and Growth Rate of Liposomes Drug Delivery 2011-2016 30
Figure Europe Capacity Utilization Rate of Liposomes Drug Delivery 2011-2016 31
Figure Europe Revenue (M USD) and Growth Rate of Liposomes Drug Delivery 2011-2016 31
Figure China Capacity (K Unit), Production (K Unit) and Growth Rate of Liposomes Drug Delivery 2011-2016 32
Figure China Capacity Utilization Rate of Liposomes Drug Delivery 2011-2016 32
Figure China Revenue (M USD) and Growth Rate of Liposomes Drug Delivery 2011-2016 33
Figure Asia (Ex. China) Capacity (K Unit), Production (K Unit) and Growth Rate of Liposomes Drug Delivery 2011-2016 33
Figure Asia (Ex. China) Capacity Utilization Rate of Liposomes Drug Delivery 2011-2016 34
Figure Asia (Ex. China) Revenue (M USD) and Growth Rate of Liposomes Drug Delivery 2011-2016 34
Table Global Production (K Unit) of Liposomes Drug Delivery by Types 2011-2016 35
Figure Global Production Market Share of Liposomes Drug Delivery by Types in 2011 35
Figure Global Production Market Share of Liposomes Drug Delivery by Types in 2015 36
Table Global Revenue (M USD) of Liposomes Drug Delivery by Types 2011-2016 36
Figure Global Revenue Market Share of Liposomes Drug Delivery by Types in 2011 37
Figure Global Revenue Market Share of Liposomes Drug Delivery by Types in 2015 37
Table Global and Major Manufacturers Capacity (K Unit) of Liposomes Drug Delivery 2011-2016 38
Table Global Capacity Market Share of Liposomes Drug Delivery Major Manufacturers 2011-2016 38
Figure Global Capacity Market Share of Liposomes Drug Delivery Major Manufacturers in 2011 39
Figure Global Capacity Market Share of Liposomes Drug Delivery Major Manufacturers in 2015 40
Table Global and Major Manufacturers Production (K Unit) of Liposomes Drug Delivery 2011-2016 40
Table Global Production Market Share of Liposomes Drug Delivery Major Manufacturers 2011-2016 41
Figure Global Production Market Share of Liposomes Drug Delivery Major Manufacturers in 2011 42
Figure Global Production Market Share of Liposomes Drug Delivery Major Manufacturers in 2015 43
Table Global and Major Manufacturers Revenue (M USD) of Liposomes Drug Delivery 2011-2016 43
Table Global Revenue Market Share of Liposomes Drug Delivery Major Manufacturers 2011-2016 44
Figure Global Revenue Market Share of Liposomes Drug Delivery Major Manufacturers in 2011 45
Figure Global Revenue Market Share of Liposomes Drug Delivery Major Manufacturers in 2015 46
Table Price (USD/Unit) of Liposomes Drug Delivery by Regions 2011-2016 47
Figure Price (USD/Unit) of Liposomes Drug Delivery by Regions in 2015 47
Table Gross Margin of Liposomes Drug Delivery by Regions 2011-2016 48
Figure Gross Margin of Liposomes Drug Delivery by Regions in 2015 48
Table Price (USD/Unit) of Liposomes Drug Delivery by Types 2011-2016 48
Figure Price (USD/Unit) of Liposomes Drug Delivery by Types in 2015 49
Table Gross Margin of Liposomes Drug Delivery by Types 2011-2016 49
Figure Gross Margin of Liposomes Drug Delivery by Types in 2015 50
Table Price (USD/Unit) of Liposomes Drug Delivery by Manufacturers 2011-2016 50
Figure Price (USD/Unit) of Liposomes Drug Delivery by Manufacturers in 2015 51
Table Gross Margin of Liposomes Drug Delivery by Manufacturers 2011-2016 51
Figure Gross Margin of Liposomes Drug Delivery by Manufacturers in 2015 52
Table Global Consumption Volume (K Unit) of Liposomes Drug Delivery by Regions 2011-2016 53
Figure Global Consumption Volume Market Share of Liposomes Drug Delivery by Regions in 2011 54
Figure Global Consumption Volume Market Share of Liposomes Drug Delivery by Regions in 2015 54
Table Global Consumption Value (M USD) of Liposomes Drug Delivery by Regions 2011-2016 55
Figure Global Consumption Value Market Share of Liposomes Drug Delivery by Regions in 2011 55
Figure Global Consumption Value Market Share of Liposomes Drug Delivery by Regions in 2015 56
Figure Global Consumption Volume (K Unit) and Growth Rate of Liposomes Drug Delivery 2011-2016 57
Figure Global Consumption Value (M USD) and Growth Rate of Liposomes Drug Delivery 2011-2016 58
Figure North America Consumption Volume (K Unit) and Growth Rate of Liposomes Drug Delivery 2011-2016 58
Figure North America Consumption Value (M USD) and Growth Rate of Liposomes Drug Delivery 2011-2016 59
Figure Europe Consumption Volume (K Unit) and Growth Rate of Liposomes Drug Delivery 2011-2016 59
Figure Europe Consumption Value (M USD) and Growth Rate of Liposomes Drug Delivery 2011-2016 60
Figure China Consumption Volume (K Unit) and Growth Rate of Liposomes Drug Delivery 2011-2016 60
Figure China Consumption Value (M USD) and Growth Rate of Liposomes Drug Delivery 2011-2016 61
Figure Asia (Ex. China) Consumption Volume (K Unit) and Growth Rate of Liposomes Drug Delivery 2011-2016 61
Figure Asia (Ex. China) Consumption Value (M USD) and Growth Rate of Liposomes Drug Delivery 2011-2016 62
Table Global Consumption Value (M USD) of Liposomes Drug Delivery by Types 2011-2016 62
Figure Global Consumption Value Market Share of Liposomes Drug Delivery by Types in 2011 63
Figure Global Consumption Value Market Share of Liposomes Drug Delivery by Types in 2015 63
Table Global Consumption Volume (K Unit) of Liposomes Drug Delivery by Applications 2011-2016 64
Figure Global Consumption Volume Market Share of Liposomes Drug Delivery by Applications in 2011 64
Figure Global Consumption Volume Market Share of Liposomes Drug Delivery by Applications in 2015 65
Table Global Consumption Value (M USD) of Liposomes Drug Delivery by Applications 2011-2016 65
Figure Global Consumption Value Market Share of Liposomes Drug Delivery by Applications in 2011 66
Figure Global Consumption Value Market Share of Liposomes Drug Delivery by Applications in 2015 67
Table Sale Price (USD/Unit) of Liposomes Drug Delivery by Regions 2011-2016 67
Figure Sale Price (USD/Unit) of Liposomes Drug Delivery by Regions in 2015 68
Table Sale Price (USD/Unit) of Liposomes Drug Delivery by Types 2011-2016 68
Figure Sale Price (USD/Unit) of Liposomes Drug Delivery by Types in 2015 69
Table Sale Price (USD/Unit) of Liposomes Drug Delivery by Applications 2011-2016 69
Figure Sale Price (USD/Unit) of Liposomes Drug Delivery by Applications in 2015 70
Table North America Supply, Consumption and Gap of Liposomes Drug Delivery 2011-2016 (K Unit) 71
Table Europe Supply, Consumption and Gap of Liposomes Drug Delivery 2011-2016 (K Unit) 71
Table China Supply, Consumption and Gap of Liposomes Drug Delivery 2011-2016 (K Unit) 71
Table Asia (Ex. China) Supply, Consumption and Gap of Liposomes Drug Delivery 2011-2016 (K Unit) 71
Table Global Capacity (K Unit), Production (K Unit), Price (USD/Unit), Cost (USD/Unit), Revenue (M USD) and Gross Margin of Liposomes Drug Delivery 2011-2016 72
Table North America Capacity (K Unit), Production (K Unit), Price (USD/Unit), Cost (USD/Unit), Revenue (M USD) and Gross Margin of Liposomes Drug Delivery 2011-2016 72
Table North America Supply, Import, Export and Consumption of Liposomes Drug Delivery 2011-2016 (K Unit) 73
Table Europe Capacity (K Unit), Production (K Unit), Price (USD/Unit), Cost (USD/Unit), Revenue (M USD) and Gross Margin of Liposomes Drug Delivery 2011-2016 73
Table Europe Supply, Import, Export and Consumption of Liposomes Drug Delivery 2011-2016 (K Unit) 73
Table China Capacity (K Unit), Production (K Unit), Price (USD/Unit), Cost (USD/Unit), Revenue (M USD) and Gross Margin of Liposomes Drug Delivery 2011-2016 74
Table China Supply, Import, Export and Consumption of Liposomes Drug Delivery 2011-2016 (K Unit) 74
Table Asia (Ex. China) Capacity (K Unit), Production (K Unit), Price (USD/Unit), Cost (USD/Unit), Revenue (M USD) and Gross Margin of Liposomes Drug Delivery 2011-2016 75
Table Asia (Ex. China) Supply, Import, Export and Consumption of Liposomes Drug Delivery 2011-2016 (K Unit) 75
Table Johnson & Johnson Company Profile 76
Figure Liposomes Drug Delivery Product Picture of Johnson & Johnson 77
Table Liposomes Drug Delivery Product Specifications of Johnson & Johnson 77
Table Liposomes Drug Delivery Capacity (K Unit), Production (K Unit), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Johnson & Johnson 2011-2016 78
Figure Liposomes Drug Delivery Capacity (K Unit), Production (K Unit) and Growth Rate of Johnson & Johnson 2011-2016 79
Figure Liposomes Drug Delivery Revenue (M USD) and Global Market Share of Johnson & Johnson 2011-2016 79
Table Gilead Sciences Company Profile 80
Figure Liposomes Drug Delivery Product Picture and Specifications of Gilead Sciences 81
Table Liposomes Drug Delivery Capacity (K Unit), Production (K Unit), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Gilead Sciences 2011-2016 81
Figure Liposomes Drug Delivery Capacity (K Unit), Production (K Unit) and Growth Rate of Gilead Sciences 2011-2016 82
Figure Liposomes Drug Delivery Revenue (M USD) and Global Market Share of Gilead Sciences 2011-2016 82
Table Luye Pharma Company Profile 83
Figure Liposomes Drug Delivery Product Picture and Specifications of Luye Pharma 84
Table Liposomes Drug Delivery Capacity (K Unit), Production (K Unit), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Luye Pharma 2011-2016 84
Figure Liposomes Drug Delivery Capacity (K Unit), Production (K Unit) and Growth Rate of Luye Pharma 2011-2016 85
Figure Liposomes Drug Delivery Revenue (M USD) and Global Market Share of Luye Pharma 2011-2016 85
Table Sun Pharmaceutical Company Profile 86
Figure Liposomes Drug Delivery Product Picture of Sun Pharmaceutical 87
Figure Liposomes Drug Delivery Product Specifications of Sun Pharmaceutical 87
Table Liposomes Drug Delivery Capacity (K Unit), Production (K Unit), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Sun Pharmaceutical 2011-2016 88
Figure Liposomes Drug Delivery Capacity (K Unit), Production (K Unit) and Growth Rate of Sun Pharmaceutical 2011-2016 88
Figure Liposomes Drug Delivery Revenue (M USD) and Global Market Share of Sun Pharmaceutical 2011-2016 89
Table Pacira Company Profile 89
Figure Liposomes Drug Delivery Product Picture and Specifications of Pacira 90
Table Liposomes Drug Delivery Capacity (K Unit), Production (K Unit), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Pacira 2011-2016 91
Figure Liposomes Drug Delivery Capacity (K Unit), Production (K Unit) and Growth Rate of Pacira 2011-2016 91
Figure Liposomes Drug Delivery Revenue (M USD) and Global Market Share of Pacira 2011-2016 92
Table Fudan-Zhangjiang Company Profile 92
Table Liposomes Drug Delivery Product Picture and Specifications of Fudan-Zhangjiang 93
Table Liposomes Drug Delivery Capacity (K Unit), Production (K Unit), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Fudan-Zhangjiang 2011-2016 94
Figure Liposomes Drug Delivery Capacity (K Unit), Production (K Unit) and Growth Rate of Fudan-Zhangjiang 2011-2016 95
Figure Liposomes Drug Delivery Revenue (M USD) and Global Market Share of Fudan-Zhangjiang 2011-2016 95
Table Sigma-Tau Group Company Profile 96
Table Liposomes Drug Delivery Product Picture and Specifications of Sigma-Tau Group 97
Table Liposomes Drug Delivery Capacity (K Unit), Production (K Unit), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Sigma-Tau Group 2011-2016 98
Figure Liposomes Drug Delivery Capacity (K Unit), Production (K Unit) and Growth Rate of Sigma-Tau Group 2011-2016 98
Figure Liposomes Drug Delivery Revenue (M USD) and Global Market Share of Sigma-Tau Group 2011-2016 99
Table Teva Pharmaceutical Company Profile 99
Figure Liposomes Drug Delivery Product Picture and Specifications of Teva Pharmaceutical 100
Table Liposomes Drug Delivery Capacity (K Unit), Production (K Unit), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Teva Pharmaceutical 2011-2016 101
Figure Liposomes Drug Delivery Capacity (K Unit), Production (K Unit) and Growth Rate of Teva Pharmaceutical 2011-2016 101
Figure Liposomes Drug Delivery Revenue (M USD) and Global Market Share of Teva Pharmaceutical 2011-2016 102
Table CSPC Company Profile 102
Figure Liposomes Drug Delivery Product Picture and Specifications of CSPC 103
Table Liposomes Drug Delivery Capacity (K Unit), Production (K Unit), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of CSPC 2011-2016 104
Figure Liposomes Drug Delivery Capacity (K Unit), Production (K Unit) and Growth Rate of CSPC 2011-2016 104
Figure Liposomes Drug Delivery Revenue (M USD) and Global Market Share of CSPC 2011-2016 105
Table Novartis Company Profile 105
Figure Liposomes Drug Delivery Product Picture and Specifications of Novartis 106
Table Liposomes Drug Delivery Capacity (K Unit), Production (K Unit), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Novartis 2011-2016 107
Figure Liposomes Drug Delivery Capacity (K Unit), Production (K Unit) and Growth Rate of Novartis 2011-2016 107
Figure Liposomes Drug Delivery Revenue (M USD) and Global Market Share of Novartis 2011-2016 108
Table Crucell Company Profile 108
Figure Liposomes Drug Delivery Product Picture and Specifications of Crucell 109
Table Liposomes Drug Delivery Capacity (K Unit), Production (K Unit), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Crucell 2011-2016 110
Figure Liposomes Drug Delivery Capacity (K Unit), Production (K Unit) and Growth Rate of Crucell 2011-2016 110
Figure Liposomes Drug Delivery Revenue (M USD) and Global Market Share of Crucell 2011-2016 111
Table Celsion Corporation Company Profile 111
Table Liposomes Drug Delivery Test of Celsion Corporation 112
Table Liposomes Drug Delivery Capacity (K Unit), Production (K Unit), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Celsion Corporation 2011-2016 113
Figure Liposomes Drug Delivery Capacity (K Unit), Production (K Unit) and Growth Rate of Celsion Corporation 2011-2016 114
Figure Liposomes Drug Delivery Revenue (M USD) and Global Market Share of Celsion Corporation 2011-2016 114
Table Kingond Pharm Company Profile 115
Figure Liposomes Drug Delivery Product Picture and Specifications of Kingond Pharm 116
Table Liposomes Drug Delivery Capacity (K Unit), Production (K Unit), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Kingond Pharm 2011-2016 116
Figure Liposomes Drug Delivery Capacity (K Unit), Production (K Unit) and Growth Rate of Kingond Pharm 2011-2016 117
Figure Liposomes Drug Delivery Revenue (M USD) and Global Market Share of Kingond Pharm 2011-2016 117
Table Shanghai New Asia Company Profile 118
Figure Liposomes Drug Delivery Product Picture and Specifications of Shanghai New Asia 119
Table Liposomes Drug Delivery Capacity (K Unit), Production (K Unit), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Shanghai New Asia 2011-2016 119
Figure Liposomes Drug Delivery Capacity (K Unit), Production (K Unit) and Growth Rate of Shanghai New Asia 2011-2016 120
Figure Liposomes Drug Delivery Revenue (M USD) and Global Market Share of Shanghai New Asia 2011-2016 120
Table Spectrum Pharmaceuticals Company Profile 121
Table Liposomes Drug Delivery Product Picture and Specifications of Spectrum Pharmaceuticals 122
Table Liposomes Drug Delivery Capacity (K Unit), Production (K Unit), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Spectrum Pharmaceuticals 2011-2016 122
Figure Liposomes Drug Delivery Capacity (K Unit), Production (K Unit) and Growth Rate of Spectrum Pharmaceuticals 2011-2016 123
Figure Liposomes Drug Delivery Revenue (M USD) and Global Market Share of Spectrum Pharmaceuticals 2011-2016 123
Figure Marketing Channels of Liposomes Drug Delivery 124
Table Traders or Distributors with Contact Information of Liposomes Drug Delivery 125
Table Ex-work Price, Channel Price and End Buyer Price of Liposomes Drug Delivery (USD/Unit) 125
Table Regional Import and Trade of Liposomes Drug Delivery (K Unit) 126
Table Regional Export and Trade of Liposomes Drug Delivery (K Unit) 126
Table Major Raw Materials Suppliers with Contact Information of Liposomes Drug Delivery 127
Table Major Consumers with Contact Information of Liposomes Drug Delivery 127
Figure Supply Chain Relationship Analysis of Liposomes Drug Delivery 129
Figure Current Trends in Liposomes 130
Table Global Capacity (K Unit) of Liposomes Drug Delivery by Regions 2016-2021 131
Figure Global Capacity Market Share of Liposomes Drug Delivery by Regions in 2016 132
Figure Global Capacity Market Share of Liposomes Drug Delivery by Regions in 2021 132
Table Global Production (K Unit) of Liposomes Drug Delivery by Regions 2016-2021 133
Figure Global Production Market Share of Liposomes Drug Delivery by Regions in 2016 133
Figure Global Production Market Share of Liposomes Drug Delivery by Regions in 2021 134
Table Global Revenue (M USD) of Liposomes Drug Delivery by Regions 2016-2021 134
Figure Global Revenue Market Share of Liposomes Drug Delivery by Regions in 2016 135
Figure Global Revenue Market Share of Liposomes Drug Delivery by Regions in 2021 135
Figure Global Capacity (K Unit), Production (K Unit) and Growth Rate of Liposomes Drug Delivery 2016-2021 136
Figure Global Capacity Utilization Rate of Liposomes Drug Delivery 2016-2021 137
Figure Global Revenue (M USD) and Growth Rate of Liposomes Drug Delivery 2016-2021 137
Figure North America Capacity (K Unit), Production (K Unit) and Growth Rate of Liposomes Drug Delivery 2016-2021 138
Figure North America Capacity Utilization Rate of Liposomes Drug Delivery 2016-2021 138
Figure North America Revenue (M USD) and Growth Rate of Liposomes Drug Delivery 2016-2021 139
Figure Europe Capacity (K Unit), Production (K Unit) and Growth Rate of Liposomes Drug Delivery 2016-2021 139
Figure Europe Capacity Utilization Rate of Liposomes Drug Delivery 2016-2021 140
Figure Europe Revenue (M USD) and Growth Rate of Liposomes Drug Delivery 2016-2021 140
Figure China Capacity (K Unit), Production (K Unit) and Growth Rate of Liposomes Drug Delivery 2016-2021 141
Figure China Capacity Utilization Rate of Liposomes Drug Delivery 2016-2021 141
Figure China Revenue (M USD) and Growth Rate of Liposomes Drug Delivery 2016-2021 142
Figure Asia (Ex China) Capacity (K Unit), Production (K Unit) and Growth Rate of Liposomes Drug Delivery 2016-2021 142
Figure Asia (Ex China) Capacity Utilization Rate of Liposomes Drug Delivery 2016-2021 143
Figure Asia (Ex China) Revenue (M USD) and Growth Rate of Liposomes Drug Delivery 2016-2021 143
Table Global Consumption Volume (K Unit) of Liposomes Drug Delivery by Regions 2016-2021 144
Figure Global Consumption Volume Market Share of Liposomes Drug Delivery by Regions in 2016 144
Figure Global Consumption Volume Market Share of Liposomes Drug Delivery by Regions in 2021 145
Table Global Consumption Value (M USD) of Liposomes Drug Delivery by Regions 2016-2021 145
Figure Global Consumption Value Market Share of Liposomes Drug Delivery by Regions in 2016 146
Figure Global Consumption Value Market Share of Liposomes Drug Delivery by Regions in 2021 146
Figure Global Consumption Volume (K Unit) and Growth Rate of Liposomes Drug Delivery 2016-2021 147
Figure Global Consumption Value (M USD) and Growth Rate of Liposomes Drug Delivery 2016-2021 148
Figure North America Consumption Volume (K Unit) and Growth Rate of Liposomes Drug Delivery 2016-2021 148
Figure North America Consumption Value (M USD) and Growth Rate of Liposomes Drug Delivery 2016-2021 149
Figure Europe Consumption Volume (K Unit) and Growth Rate of Liposomes Drug Delivery 2016-2021 149
Figure Europe Consumption Value (M USD) and Growth Rate of Liposomes Drug Delivery 2016-2021 150
Figure China Consumption Volume (K Unit) and Growth Rate of Liposomes Drug Delivery 2016-2021 150
Figure China Consumption Value (M USD) and Growth Rate of Liposomes Drug Delivery 2016-2021 151
Figure Asia (Ex China) Consumption Volume (K Unit) and Growth Rate of Liposomes Drug Delivery 2016-2021 151
Figure Asia (Ex China) Consumption Value (M USD) and Growth Rate of Liposomes Drug Delivery 2016-2021 152
Table Global Supply, Consumption and Gap of Liposomes Drug Delivery 2016-2021 (K Unit) 152
Table North America Supply, Consumption and Gap of Liposomes Drug Delivery 2016-2021 (K Unit) 153
Table Europe Supply, Consumption and Gap of Liposomes Drug Delivery 2016-2021 (K Unit) 153
Table China Supply, Consumption and Gap of Liposomes Drug Delivery 2016-2021 (K Unit) 153
Table Asia (Ex China) Supply, Consumption and Gap of Liposomes Drug Delivery 2016-2021 (K Unit) 153
Table Global Capacity (K Unit), Production (K Unit), Price (USD/Unit), Cost (USD/Unit), Revenue (M USD) and Gross Margin of Liposomes Drug Delivery 2016-2021 154
Table North America Capacity (K Unit), Production (K Unit), Price (USD/Unit), Cost (USD/Unit), Revenue (M USD) and Gross Margin of Liposomes Drug Delivery 2016-2021 154
Table Europe Capacity (K Unit), Production (K Unit), Price (USD/Unit), Cost (USD/Unit), Revenue (M USD) and Gross Margin of Liposomes Drug Delivery 2016-2021 155
Table China Capacity (K Unit), Production (K Unit), Price (USD/Unit), Cost (USD/Unit), Revenue (M USD) and Gross Margin of Liposomes Drug Delivery 2016-2021 155
Table Asia (Ex China) Capacity (K Unit), Production (K Unit), Price (USD/Unit), Cost (USD/Unit), Revenue (M USD) and Gross Margin of Liposomes Drug Delivery 2016-2021 156
Table New Project SWOT Analysis of Liposomes Drug Delivery 157
Table New Project Investment Feasibility Analysis of Liposomes Drug Delivery 158
Similar Reports
Proteins that are designed and engineered in the laboratory for pharmaceutical interventions to treat different diseases are known as protein therapeutics. The global protein therapeutics market accounted for $140,109 million in 2016, and is anticipated to rea...
- Publish Date: November 14, 2017
- $5370
Umbilical cord blood bank is storage facility that collects cord blood after the childbirth from placenta. Cord blood is rich source of stem cell used in treatment of different chronic diseases. Private and public cord blood banks are the two major types of banks that are prevalent in th...
- Publish Date: July 20, 2017
- $5370
The pharmaceutical agents that are administered to treat, diagnose, and prevent life-threatening diseases (rare diseases) are known as orphan drugs. The global orphan drugs market accounted for $106 billion in 2015, and is anticipated to reach $169 billio...
- Publish Date: April 24, 2017
- $5370
